COVID-19 mRNA vaccine (BNT162) Name of the Medicinal Product - Form to be diluted 30 µg/dose for adults and ≥12 years (purple cap)

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

Comirnaty 30 micrograms/dose concentrate for dispersion for injection
COVID-19 mRNA Vaccine (nucleoside modified)